NOTE 7: Income Taxes
The Company did not record a provision for income taxes for the three or six months ended June 30, 2021 because it expects to generate a loss for the year ending December 31, 2021 and the Company’s net deferred tax assets continue to be fully offset by a valuation allowance.
As of June 30, 2021, and December 31, 2020, the Company had deferred tax assets of approximately $9.0 million and $3.1 million, respectively, each of which was fully offset by a valuation allowance. During the three months ended June 30, 2021 and June 30, 2020, the Company did not record an income tax benefit (expense) as a result of the full valuation allowances recorded against its deferred tax assets. During the six months ended June 30, 2021 and the period from inception (January 21, 2020) to June 30, 2020, the Company did not record an income tax benefit (expense) as a result of the full valuation allowances recorded against its deferred tax assets.
There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its positions.
NOTE 8: Commitments and Contingencies
Legal Proceedings
From time to time, we may become involved in legal proceedings or be subject to claims in the ordinary course of business. We currently believe that we are not a party to any legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition, or results of operations. Regardless of outcome, such proceeding or claims can have an adverse impact on us because of defense and settlement costs, diversion of resources and other factors and there can be no assurances that favorable outcomes will be obtained.
In connection with our acquisition by DCRB (our predecessor company), certain of DCRB’s stockholders filed lawsuits against DCRB and its directors asserting claims for breaches of fiduciary duty. These complaints allege that the DCRB board members breached their fiduciary duties by in connection with the merger by allegedly agreeing to the transaction following an inadequate process and at an unfair price, and by allegedly disseminating inaccurate or incomplete information concerning the transaction. These complaints seek, among other things, injunctive relief and an award of attorneys’ fees. The defendants in these cases have not yet answered these complaints and we believe that these pending and threatened lawsuits are without merit.
NOTE 9: Stock Compensation
During the three months ended June 30, 2021, the Company did not grant any stock options. During the six months ended June 30, 2021, the Company granted 76,000 stock options with a weighted average grant date fair value of $2.97 per share that vest over five years. During the three months ended June 30, 2021, 10,000 options were exercised resulting in proceeds of $3 thousand, and 20,000 options were forfeited. During the six months ended June 30, 2021, 75,000 options were exercised resulting in proceeds of $190 thousand, and 26,000 options were forfeited. There was no option activity in the three months ended June 30, 2020 or the period from inception (January 21, 2020) to June 30, 2020.
The Company granted 500,000 restricted stock units during the three months ended June 30, 2021 with a weighted average grant date fair value of $9.10 per share. The Company granted 992,000 restricted stock units during the six months ended June 30, 2021 with a weighted average grant date fair value of $8.39 per share. The restricted stock units granted during the three months and six months ended June 30, 2021 vest over period ranging from four to five years. The Company did not grant restricted stock units in the three months ended June 30, 2020 or the period from inception (January 21, 2020) to June 30, 2020.
As of June 30, 2021, there were 11,347,500 options with a weighted average exercise value of $2.01, and 992,000 restricted stock units outstanding. There were no stock options or restricted stock units outstanding as of June 30, 2020. The Company recognized stock-based compensation costs of $580 thousand in the three months ended June 30, 2021, and $877 thousand during the six months ended June 30, 2021 related to the vesting of stock options and restricted stock units granted in the current and prior periods.